What question did this study set out to answer?

To investigate the direct functional and physical interactions between sarcolipin, phospholamban, and SERCA-type calcium pumps in cell models and skeletal muscle.

April 1, 2003Annals of the New York Academy of Sciences

The Regulation of SERCA‐Type Pumps by Phospholamban and Sarcolipin

View Full Paper

Ask AI

Bookmark

To investigate the direct functional and physical interactions between sarcolipin, phospholamban, and SERCA-type calcium pumps in cell models and skeletal muscle.
Coexpressed SERCA1a or SERCA2a alongside sarcolipin (SLN) and phospholamban (PLN) in HEK-293 cells to assess functional inhibition and complex assembly.
Injected SLN cDNA directly into rat soleus muscle to measure contractile force characteristics, fatigability under repeated stimulation, and calcium uptake in muscle homogenates.
Coexpression of both SLN and PLN with SERCA pumps produced superinhibition by promoting PLN monomer availability within a ternary regulatory complex.
Overexpression of SLN in rat soleus muscle significantly reduced twitch and tetanic peak force amplitude, slowed maximal contraction and relaxation rates, and accelerated fatigue.
Sarcoplasmic reticulum calcium uptake was impaired in SLN-overexpressing muscle homogenates, indicating diminished intracellular calcium stores.

Structured PICO

Population

HEK-293 cells and rat soleus muscle

Intervention

Coexpression of SERCA1a or SERCA2a with SLN and PLN; direct injection of SLN cDNA into rat soleus muscle

Outcome

SERCA Ca(2+) affinity, muscle force characteristics, and Ca(2+) uptakesurrogate

SLN and PLN interact to superinhibit SERCA pumps, and SLN overexpression impairs muscle contractility and calcium uptake.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

No immediate clinical implications from this animal model; leaves open therapeutic targeting of SLN-PLN-SERCA interactions in human muscle disease.

Cite This Study

MacLennan et al. (2003) studied this question.

synapsesocial.com/papers/6a82c22fa6b9f3b4bf8ad5de https://doi.org/10.1111/j.1749-6632.2003.tb07231.x

View Full Paper

Ask AI

Bookmark

Implication

No immediate clinical implications from this animal model; leaves open therapeutic targeting of SLN-PLN-SERCA interactions in human muscle disease.

The Regulation of SERCA‐Type Pumps by Phospholamban and Sarcolipin

Key Points

Structured PICO

Discussion

Implication

Cite This Study

The Regulation of SERCA‐Type Pumps by Phospholamban and Sarcolipin

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider